Properly scaled and targeted AAV2-NRTN (neurturin) to the substantia nigra is safe, effective and causes no weight loss: support for nigral targeting in Parkinson's disease (Q39518245)
Jump to navigation
Jump to search
scientific article published on 17 June 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Properly scaled and targeted AAV2-NRTN (neurturin) to the substantia nigra is safe, effective and causes no weight loss: support for nigral targeting in Parkinson's disease |
scientific article published on 17 June 2011 |
Statements
1 reference
Properly scaled and targeted AAV2-NRTN (neurturin) to the substantia nigra is safe, effective and causes no weight loss: support for nigral targeting in Parkinson's disease (English)
1 reference
Jeffrey H Kordower
1 reference
Raymond T Bartus
1 reference
Lamar Brown
1 reference
Alistair Wilson
1 reference
Brian Kruegel
1 reference
Joao Siffert
1 reference
Eugene M Johnson
1 reference
Christopher D Herzog
1 reference
17 June 2011
1 reference
1 reference
Identifiers
1 reference